In Brief: Alpharma
This article was originally published in The Tan Sheet
Executive Summary
Alpharma: Receives ANDA "tentative" approval for a private label ibuprofen oral suspension Jan. 15. The approval follows that of Perrigo's private label children's oral ibuprofen suspension, for which final market approval is subject to expiration of marketing exclusivity for McNeil's Children's Motrin on June 16 ("The Tan Sheet" Sept. 15, 1997, In Brief)...